Literature DB >> 17364025

Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice.

Noriaki Okamoto1, Risa Chihara, Chiori Shimizu, Sogo Nishimoto, Takeshi Watanabe.   

Abstract

We previously demonstrated that artificial lymph nodes (aLNs) could be generated in mice by the implantation of stromal cell-embedded biocompatible scaffolds into their renal subcapsular spaces. T and B cell domains that form in aLNs have immune response functions similar to those of follicles of normal lymphoid tissue. In the present study, we show that the aLNs were transplantable to normal as well as SCID mice, where they efficiently induced secondary immune responses. Antigen-specific secondary responses were strongly induced in aLNs even 4 weeks after their transplantation. The antigen-specific antibody responses in lymphocyte-deficient SCID mice receiving transplanted aLNs were substantial. The cells from the aLNs migrated to the SCID mouse spleen and BM, where they expanded to generate large numbers of antigen-specific antibody-forming cells. Secondary responses were maintained over time after immunization (i.e., antigen challenge), indicating that aLNs can support the development of memory B cells and long-lived plasma cells. Memory CD4(+) T cells were enriched in the aLNs and spleens of aLN-transplanted SCID mice. Our results indicate that aLNs support strong antigen-specific secondary antibody responses in immunodeficient mice and suggest the possibility of future clinical applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364025      PMCID: PMC1810575          DOI: 10.1172/JCI30379

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

Review 2.  Homing and cellular traffic in lymph nodes.

Authors:  Ulrich H von Andrian; Thorsten R Mempel
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

Review 3.  FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity.

Authors:  Volker Brinkmann; Kevin R Lynch
Journal:  Curr Opin Immunol       Date:  2002-10       Impact factor: 7.486

4.  Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells.

Authors:  Satoshi Fukuyama; Takachika Hiroi; Yoshifumi Yokota; Paul D Rennert; Manabu Yanagita; Naotoshi Kinoshita; Seigo Terawaki; Takashi Shikina; Masafumi Yamamoto; Yuichi Kurono; Hiroshi Kiyono
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

5.  Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice.

Authors:  Shu-Cheng Chen; Galya Vassileva; David Kinsley; Sandra Holzmann; Denise Manfra; Maria T Wiekowski; Nikolaus Romani; Sergio A Lira
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

Review 6.  Signaling and biological actions of sphingosine 1-phosphate.

Authors:  Timothy Hla
Journal:  Pharmacol Res       Date:  2003-05       Impact factor: 7.658

7.  Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform.

Authors:  Naotoshi Sugimoto; Noriko Takuwa; Hiroyuki Okamoto; Sotaro Sakurada; Yoh Takuwa
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

8.  Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse.

Authors:  Katsuaki Sato; Naohide Yamashita; Naomi Yamashita; Masanori Baba; Takami Matsuyama
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

9.  Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.

Authors:  Sanjiv A Luther; Afshin Bidgol; Diana C Hargreaves; Andrea Schmidt; Ying Xu; Jyothi Paniyadi; Mehrdad Matloubian; Jason G Cyster
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

10.  Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase.

Authors:  Danielle L Drayton; Xiaoyan Ying; Jason Lee; Werner Lesslauer; Nancy H Ruddle
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  31 in total

Review 1.  New insights into the development of lymphoid tissues.

Authors:  Serge A van de Pavert; Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

Review 2.  Lymphatic tissue engineering: progress and prospects.

Authors:  Thomas Hitchcock; Laura Niklason
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

3.  Stromal cells as trend-setters for cells migrating into the lymph node.

Authors:  M Buettner; O Dittrich-Breiholz; C S Falk; M Lochner; A Smoczek; F Menzel; M Bornemann; U Bode
Journal:  Mucosal Immunol       Date:  2014-11-05       Impact factor: 7.313

4.  Coordinated regulation of lymph node vascular-stromal growth first by CD11c+ cells and then by T and B cells.

Authors:  Susan Chyou; Fairouz Benahmed; Jingfeng Chen; Varsha Kumar; Sha Tian; Martin Lipp; Theresa T Lu
Journal:  J Immunol       Date:  2011-10-26       Impact factor: 5.422

5.  Substrate-bound CCL21 and ICAM1 combined with soluble IL-6 collectively augment the expansion of antigen-specific murine CD4+ T cells.

Authors:  Shimrit Adutler-Lieber; Irina Zaretsky; Helena Sabany; Elena Kartvelishvily; Ofra Golani; Benjamin Geiger; Nir Friedman
Journal:  Blood Adv       Date:  2017-06-15

Review 6.  Designing natural and synthetic immune tissues.

Authors:  Emily A Gosselin; Haleigh B Eppler; Jonathan S Bromberg; Christopher M Jewell
Journal:  Nat Mater       Date:  2018-05-21       Impact factor: 43.841

Review 7.  Image-guided dendritic cell-based vaccine immunotherapy in murine carcinoma models.

Authors:  Bin Wang; Chong Sun; Sijia Wang; Na Shang; Matteo Figini; Quanhong Ma; Shanzhi Gu; Daniele Procissi; Vahid Yaghmai; Guoxin Li; Andrew Larson; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 8.  Synthetic immune niches for cancer immunotherapy.

Authors:  Jorieke Weiden; Jurjen Tel; Carl G Figdor
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

Review 9.  Cell and tissue engineering in lymph nodes for cancer immunotherapy.

Authors:  Alexander J Najibi; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2020-08-01       Impact factor: 15.470

Review 10.  Tissue engineering and regeneration of lymphatic structures.

Authors:  Evan Weitman; Daniel Cuzzone; Babak J Mehrara
Journal:  Future Oncol       Date:  2013-09       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.